The Latin America, Middle East and Africa Liver Health Supplements Market would witness market growth of 5.26% CAGR during the forecast period (2019-2025). Throughout the Middle East and North Africa, gastrointestinal and liver disorders are the main causes of death and impairment. In most countries in the region, diarrheal diseases were replaced with gastrointestinal cancers and cirrhosis. GIT cancers are on the rise in Gulf GCC countries, Jordan & Iraq. Gastrointestinal and liver diseases demonstrate variation in their prevalence pattern, incidence, mortality and overall burden that they bring. Non-alcoholic fatty liver disease prevalence is increasing rapidly and non-alcoholic steatohepatitis has now become a key indicator of liver transplantation.
Most of the available products are generic herbals of uncertain bioavailability, based on bibliographic data rather than clinical evidence. Some solutions to liver problems, for instance, contain milk thistle extract, while its main active component, silybin, is low in bioavailability. Other times, manufacturers simply mix various herbals commonly associated with liver health, regardless of clinical substantiation, control of which part of the plant should be used, or necessary interaction between the substances. Products are often marketed as 'detox' or 'liver cleanse', which misleads customers, as no product can detoxify the liver scientifically.
Based on Form, the market is segmented into Capsules, Liquids, Tablets, Powders and Other Forms. Based on Product, the market is segmented into Herbal Supplements, Vitamins & Minerals and Other Products. The report also covers geographical segmentation of Liver Health Supplements market. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Liver Health Supplements Market in LAMEA is expected to register a CAGR of 5.26% during the forecast period (2019-2025)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include The Nature’s Bounty Co. (The Carlyle Group L.P.), The Himalaya Drug Company (Himalaya Global Holdings Ltd.), NOW Foods, Inc., Integria Healthcare (Australia) Pty Ltd., Enzymedica, Inc., Jarrow Formulas, Inc., Irwin Naturals, Inc., Gaia Herbs, Inc., Swanson Health Products, Inc. (Swander Pace Capital), and Nature's Way Products LLC (Dr. Willmar Schwabe GmbH & Co. KG).
Market Segmentation:
By Form
By Product
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
